• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童神经病学:黏多糖贮积症 IIID:超微结构和基因组研究的证据。

Child Neurology: Mucopolysaccharidosis IIID: Evidence From Ultrastructural and Genomic Study.

机构信息

From the Departments of Neuropathology (R.S., Y.T.C.) and Neurology (R.R.M., P.K.K.), National Institute of Mental Health and Neurosciences, Bengaluru, India.

出版信息

Neurology. 2023 Oct 10;101(15):e1572-e1576. doi: 10.1212/WNL.0000000000207647. Epub 2023 Jul 24.

DOI:10.1212/WNL.0000000000207647
PMID:37487748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10585691/
Abstract

Mucopolysaccharidosis IIID (MPS IIID/Sanfilippo syndrome D, OMIM # 252940) is an autosomal recessive lysosomal storage disorder (LSD) and the rarest form of the mucopolysaccharidosis (MPS) III subtypes. It is caused by sequence variations in the gene encoding lysosomal enzyme N-acetyl glucosamine-6-sulphatase (GNS). Deficiency of GNS impairs catabolism of glycosaminoglycans causing accumulation of heparan sulphate within lysosomes of various tissues, which is visualized as membranous cytoplasmic bodies (MCBs) on electron microscopy. The recognition of this ultrastructural feature in a muscle biopsy instigated genetic evaluation for LSD in our case resulting in the detection of a novel pathogenic gene variant. The patient also exhibited intellectual disability since childhood, reduced vision due to pigmentary retinopathy, and behavioral abnormalities without other systemic features of MPS. In this study, we report a patient of Indian origin with MPS IIID based on a novel pathogenic variant c.1078 G>T (p.G360C) in the and the presence of MCBs in muscle biopsy, characterized by several novel findings including the occurrence of pigmentary retinopathy, which extends the clinical spectrum of MPS IIID.

摘要

黏多糖贮积症 IIID(MPS IIID/桑菲利斯综合征 D,OMIM#252940)是一种常染色体隐性溶酶体贮积症(LSD),也是黏多糖贮积症(MPS)III 型中最罕见的类型。它是由编码溶酶体酶 N-乙酰氨基葡萄糖-6-硫酸酯酶(GNS)的基因序列变异引起的。GNS 的缺乏会损害糖胺聚糖的分解代谢,导致各种组织的溶酶体中硫酸乙酰肝素的积累,这在电子显微镜下表现为膜细胞质体(MCB)。在肌肉活检中发现这种超微结构特征后,我们对 LSD 进行了遗传评估,从而发现了一种新的致病性基因突变。该患者自童年起就存在智力障碍、色素性视网膜炎导致的视力下降以及行为异常,但没有 MPS 的其他全身特征。在本研究中,我们报告了一名来自印度的 MPS IIID 患者,该患者在基因中存在 c.1078G>T(p.G360C)的新型致病性变异,并且在肌肉活检中存在 MCB,其特征是存在几种新的发现,包括色素性视网膜炎的发生,这扩展了 MPS IIID 的临床谱。

相似文献

1
Child Neurology: Mucopolysaccharidosis IIID: Evidence From Ultrastructural and Genomic Study.儿童神经病学:黏多糖贮积症 IIID:超微结构和基因组研究的证据。
Neurology. 2023 Oct 10;101(15):e1572-e1576. doi: 10.1212/WNL.0000000000207647. Epub 2023 Jul 24.
2
Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.D型桑菲利波综合征:自然病史及GNS基因中3个新突变的鉴定
Arch Neurol. 2007 Nov;64(11):1629-34. doi: 10.1001/archneur.64.11.1629.
3
Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α--Acetylglucosamine-6-Sulfatase in Neonatal Mice.用重组人α-乙酰氨基葡萄糖-6-硫酸酯酶治疗新生期小鼠黏多糖贮积症 III 型。
Mol Pharm. 2021 Jan 4;18(1):214-227. doi: 10.1021/acs.molpharmaceut.0c00831. Epub 2020 Dec 15.
4
Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations.黏多糖贮积症 IIID 型:12 例新病例和 15 例新突变。
Hum Mutat. 2010 May;31(5):E1348-60. doi: 10.1002/humu.21234.
5
Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.通过对编码N-乙酰葡糖胺-6-硫酸酯酶的GNS进行测序揭示的IIID型粘多糖贮积症(MIM 252940)的基因组基础。
Genomics. 2003 Jan;81(1):1-5. doi: 10.1016/s0888-7543(02)00014-9.
6
Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.山羊黏多糖贮积症IIID型:临床、生化、形态学及免疫组化特征
J Neuropathol Exp Neurol. 1998 Feb;57(2):148-57. doi: 10.1097/00005072-199802000-00006.
7
A novel loss-of-function mutation in the GNS gene causes Sanfilippo syndrome type D.GNS基因中的一种新型功能丧失突变导致了D型Sanfilippo综合征。
Genet Couns. 2009;20(2):133-9.
8
Glycosaminoglycans and mucopolysaccharidosis type III.糖胺聚糖和黏多糖贮积症 III 型。
Front Biosci (Landmark Ed). 2016 Jun 1;21(7):1393-409. doi: 10.2741/4463.
9
The ultrastructure of skin from a patient with mucopolysaccharidosis IIID.
Acta Neuropathol. 1997 Feb;93(2):210-3. doi: 10.1007/s004010050605.
10
Identification and characterisation of an 8.7 kb deletion and a novel nonsense mutation in two Italian families with Sanfilippo syndrome type D (mucopolysaccharidosis IIID).
Mol Genet Metab. 2007 Jan;90(1):77-80. doi: 10.1016/j.ymgme.2006.07.014. Epub 2006 Sep 20.

引用本文的文献

1
Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?黏多糖贮积症伴多发畸形综合征:这是一种黏多糖贮积症,还是一种独立的代谢疾病?
Int J Mol Sci. 2024 Sep 4;25(17):9570. doi: 10.3390/ijms25179570.

本文引用的文献

1
Epidemiology of Mucopolysaccharidoses Update.黏多糖贮积症流行病学最新进展
Diagnostics (Basel). 2021 Feb 10;11(2):273. doi: 10.3390/diagnostics11020273.
2
Novel therapies for mucopolysaccharidosis type III.用于 III 型黏多糖贮积症的新型疗法。
J Inherit Metab Dis. 2021 Jan;44(1):129-147. doi: 10.1002/jimd.12316. Epub 2020 Sep 28.
3
A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management.黏多糖贮积症的基本认识:发病率、临床特征、诊断与管理。
Intractable Rare Dis Res. 2020 Feb;9(1):1-9. doi: 10.5582/irdr.2020.01011.
4
Ophthalmological Findings in Mucopolysaccharidoses.黏多糖贮积症的眼科表现
J Clin Med. 2019 Sep 14;8(9):1467. doi: 10.3390/jcm8091467.
5
Mucopolysaccharidoses: early diagnostic signs in infants and children.黏多糖贮积症:婴儿和儿童的早期诊断迹象。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):133. doi: 10.1186/s13052-018-0550-5.
6
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.在一种新的IIID型粘多糖贮积症小鼠模型中通过腺相关病毒介导的基因疗法进行疾病矫正。
Hum Mol Genet. 2017 Apr 15;26(8):1535-1551. doi: 10.1093/hmg/ddx058.
7
Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know.神经影像学在黏多糖贮积症患者中的表现:你真正需要了解的内容。
Radiographics. 2016 Sep-Oct;36(5):1448-62. doi: 10.1148/rg.2016150168.
8
Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility.印度溶酶体贮积症的负担:来自单一诊断机构的387名患病儿童的情况
JIMD Rep. 2014;12:51-63. doi: 10.1007/8904_2013_244. Epub 2013 Jul 13.
9
Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations.黏多糖贮积症 IIID 型:12 例新病例和 15 例新突变。
Hum Mutat. 2010 May;31(5):E1348-60. doi: 10.1002/humu.21234.
10
Heparan sulfates in skeletal muscle development and physiology.硫酸乙酰肝素在骨骼肌发育和生理学中的作用。
J Cell Physiol. 2006 Feb;206(2):283-94. doi: 10.1002/jcp.20450.